110 related articles for article (PubMed ID: 20471516)
1. Cytogenetic features, clinical significance and prognostic impact of type 1 and type 2 papillary renal cell carcinoma.
Antonelli A; Tardanico R; Balzarini P; Arrighi N; Perucchini L; Zanotelli T; Cozzoli A; Zani D; Cunico SC; Simeone C
Cancer Genet Cytogenet; 2010 Jun; 199(2):128-33. PubMed ID: 20471516
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma.
Klatte T; Pantuck AJ; Said JW; Seligson DB; Rao NP; LaRochelle JC; Shuch B; Zisman A; Kabbinavar FF; Belldegrun AS
Clin Cancer Res; 2009 Feb; 15(4):1162-9. PubMed ID: 19228721
[TBL] [Abstract][Full Text] [Related]
3. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
[TBL] [Abstract][Full Text] [Related]
4. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
5. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of cytogenetic analysis in clear cell renal carcinoma: a study on 131 patients with long-term follow-up.
Antonelli A; Arrighi N; Tardanico R; Balzarini P; Zanotelli T; Corti S; Zani D; Cozzoli A; Cunico SC; Simeone C
Anticancer Res; 2010 Nov; 30(11):4705-9. PubMed ID: 21115928
[TBL] [Abstract][Full Text] [Related]
7. [Papillary renal cell carcinoma: clinico-pathologic studies of 33 cases].
Liu LN; Chen GY; Wang P; Zhang CH; Huang SF
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):102-5. PubMed ID: 15946550
[TBL] [Abstract][Full Text] [Related]
8. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D
Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis.
Gunawan B; Huber W; Holtrup M; von Heydebreck A; Efferth T; Poustka A; Ringert RH; Jakse G; Füzesi L
Cancer Res; 2001 Nov; 61(21):7731-8. PubMed ID: 11691785
[TBL] [Abstract][Full Text] [Related]
10. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
11. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features.
Kunju LP; Wojno K; Wolf JS; Cheng L; Shah RB
Hum Pathol; 2008 Jan; 39(1):96-101. PubMed ID: 17949780
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors.
Gunawan B; von Heydebreck A; Fritsch T; Huber W; Ringert RH; Jakse G; Füzesi L
Cancer Res; 2003 Oct; 63(19):6200-5. PubMed ID: 14559804
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
[TBL] [Abstract][Full Text] [Related]
14. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
Delahunt B; Eble JN; McCredie MR; Bethwaite PB; Stewart JH; Bilous AM
Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality.
Mejean A; Hopirtean V; Bazin JP; Larousserie F; Benoit H; Chrétien Y; Thiounn N; Dufour B
J Urol; 2003 Sep; 170(3):764-7. PubMed ID: 12913693
[TBL] [Abstract][Full Text] [Related]
16. A molecular classification of papillary renal cell carcinoma.
Yang XJ; Tan MH; Kim HL; Ditlev JA; Betten MW; Png CE; Kort EJ; Futami K; Furge KA; Takahashi M; Kanayama HO; Tan PH; Teh BS; Luan C; Wang K; Pins M; Tretiakova M; Anema J; Kahnoski R; Nicol T; Stadler W; Vogelzang NG; Amato R; Seligson D; Figlin R; Belldegrun A; Rogers CG; Teh BT
Cancer Res; 2005 Jul; 65(13):5628-37. PubMed ID: 15994935
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.
Kattar MM; Grignon DJ; Wallis T; Haas GP; Sakr WA; Pontes JE; Visscher DW
Mod Pathol; 1997 Nov; 10(11):1143-50. PubMed ID: 9388066
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
Klatte T; Pantuck AJ; Riggs SB; Kleid MD; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS
J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
20. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
